Wednesday, 24 April, 2024
HomeNeurologyJNS supplement reviews oral anticoagulation therapies

JNS supplement reviews oral anticoagulation therapies

The [b]Journal of Neurosurgery[/b] has announced a supplement, co-authored by [b]Perleman School of Medicine’s[/b] Dr Peter le Roux – a [b]University of Cape Town Medical School[/b] graduate – which covers the current knowledge of anticoagulant-associated intracerebral haemorrhage (AAICH) and methods in use for management of the condition. A [s]Eurekalert[/s] report notes that management of ICH poses a greater challenge when it occurs in patients who receive anticoagulation therapy, because the decreased ability of blood to clot leads to larger haemorrhages. Anticoagulants are prescribed for a variety of diagnoses such as atrial fibrillation, deep vein thrombosis, heart attack, and ischemic stroke and the number of cases of AAICH is on the rise. The supplement offers a review of current oral anticoagulation therapies.

[link url=http://www.eurekalert.org/pub_releases/2014-08/jonp-moa072914.php]Full Eurekalert report [/link]
[link url=http://thejns.org/doi/abs/10.3171/2014.8.paradigm]Journal of Neurosurgery abstract[/link]

MedicalBrief — our free weekly e-newsletter

We'd appreciate as much information as possible, however only an email address is required.